Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-10-21

Clinical Trial Update: Blackcurrants Modify Gut Microbiota and Reduce Osteoporosis and CVD Risk [Phase 1]

View source ↗

Summary

Phase 1 trial investigating blackcurrants showed potential effects on gut microbiota. The study also reported reduced risk markers for postmenopausal osteoporos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Blackcurrants (Ribes nigrum) (Ribes nigrum)

Snippet

Sponsor: University of Connecticut | Conditions: Postmenopausal Osteoporosis, Gut Microbiota | Phase 1 | Status: COMPLETED | Results posted: 2024-10-21